BSE
MARKET ANALYSIS NEWS CORPORATE INFORMATION CORPORATE ACTIONS OTHER MARKETS
Your Result on : Company News Details
Neuland Laboratories Ltd Industry :  Pharmaceuticals - Indian - Bulk Drugs
BSE Code
524558
ISIN Demat
INE794A01010
Book Value (Rs)
1255.9414887
NSE Symbol
NEULANDLAB
Divident Yield %
0.1
Market Cap
(Rs In Cr.)
16,235
P/E (TTM)
91.05
EPS (TTM)
138.98
Face Value
(Rs)
10
Back
Neuland Laboratories consolidated net profit declines 60.06% in the December 2025 quarter
09-Feb-26   Hrs IST

Net profit of Neuland Laboratories declined 60.06% to Rs 40.57 crore in the quarter ended December 2025 as against Rs 101.59 crore during the previous quarter ended December 2024. Sales rose 10.47% to Rs 439.71 crore in the quarter ended December 2025 as against Rs 398.03 crore during the previous quarter ended December 2024.

ParticularsQuarter Ended
Dec. 2025Dec. 2024% Var.
Sales439.71398.03 10
OPM %17.5421.76 -
PBDT78.4088.29 -11
PBT54.4871.98 -24
NP40.57101.59 -60

Risk Factor   |   Terms & Conditions   |   Privacy Policy   |   Disclaimer   |  Sitemap 
Important Links:   SEBI   |   NSE   |   BSE   |   MCX   |   NCDEX   |   NSDL   |   CDSL  |   FMC
SMS FINANCIAL SERVICES P. LTD -NSE SEBI No. AP1413004363 | BSE SEBI No. AP01091801121968
Ganesh S Shanbhag – AMFI Registered Mutual Fund Distributor. Registration Number – ARN-0988 – Valid Till 01/JUL/ 2027, Date of initial registration: 02/DEC/2004
2017-18 © SMS Financial Services. All rights reserved. Designed, Developed and Maintained by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)